Xiamen Yan Palace Bird's Nest Industry (1497) H1 2026 earnings summary

Executive summary

• H1 2026 revenue rose 16.5% YoY to RMB1,181.9m; net profit rose 42.9% to RMB110.7m, with gross profit up 20.3% to RMB634.8m.

• Growth reflected core-product focus, broader consumption scenarios and portfolio expansion, alongside higher online and offline sales.

Financial highlights

• Revenue increased 16.5% YoY to RMB1,181.9m; gross profit increased 20.3% to RMB634.8m.

• Operating profit was RMB147.5m vs RMB113.3m; profit before tax was RMB145.0m vs RMB110.0m.

• Net profit was RMB110.7m vs RMB77.5m; RMB107.4m was attributable to equity shareholders vs RMB75.3m.

• Net cash from operating activities was RMB190.0m vs RMB229.6m; cash and equivalents ended June at RMB690.9m, up from RMB636.1m at year-end.

Outlook and guidance

• H2 priorities: refresh pure EBN products, develop functional EBN+ and lightweight +EBN products, expand YANPEP, improve core-city stores and deepen e-commerce, membership, new retail and KA channels.

• Management expects healthcare consumption demand and industry concentration to continue rising, while citing competition and external-environment uncertainty.